Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson’s disease
Abstract Background Low-pass sequencing (LPS) has been extensively investigated for applicability to various genetic studies due to its advantages over genotype array data including cost-effectiveness. Predicting the risk of complex diseases such as Parkinson’s disease (PD) using polygenic risk scor...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-08-01
|
| Series: | Human Genomics |
| Online Access: | https://doi.org/10.1186/s40246-021-00357-w |